Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Epidural Cortical Stimulation for Depression

NCT: NCT00565617 · ACTIVE_NOT_RECRUITING

NCT IDNCT00565617
StatusACTIVE_NOT_RECRUITING
Start Date2007-10
Completion2028-12

Brief Summary

Objective: Chronic epidural cortical stimulation (ECS) involves the neurosurgical placement of an electric wire on the surface of the brain with intermittent activation. Over time, ECS modulates local and distal connected brain regions. It is being currently applied over the motor cortex to treat intractable pain. Because of the important role played by the medial prefrontal cortex in mood regulation, the goal of this study is to apply this minimally invasive neurostimulation modality over medial prefrontal cortex in severely ill depressed subjects who have failed all other attempts at treatment.

Frequently Asked Questions

What is Epidural Cortical Stimulation for Depression?

Epidural Cortical Stimulation for Depression is a clinical trial registered under NCT00565617. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT00565617?

The current status of NCT00565617 (Epidural Cortical Stimulation for Depression) is: ACTIVE_NOT_RECRUITING.

When did Epidural Cortical Stimulation for Depression start?

Epidural Cortical Stimulation for Depression started on 2007-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.